Kuipers W, van Wijngaarden I, Kruse C G, ter Horst-van Amstel M, Tulp M T, IJzerman A P
Department of Medicinal Chemistry, Solvay Duphar Research Laboratories, Weesp, The Netherlands.
J Med Chem. 1995 May 26;38(11):1942-54. doi: 10.1021/jm00011a014.
In order to explore the structural requirements for high 5-HT1A affinity, a series of aryl-substituted N1-phenylpiperazines were synthesized and evaluated for their ability to displace [3H]-8-OH-DPAT from its specific binding sites in rat frontal cortex homogenates. We found 2-methoxy substitution to be favorable, while 4-methoxy substitution was detrimental for 5-HT1A affinity. Substitution with annelated rings at the 2,3-positions was highly favorable for all investigated compounds, with the exception of a pyrrole ring. All other substitutions, except fluoro, in this class of heterobicyclic phenylpiperazines decreased affinity in the order: ortho > para > meta. The loss of affinity in the ortho and para positions is probably due to steric factors: the substituents either cause steric hindrance with the receptor or prevent the compound from adopting the appropriate conformation for binding to the 5-HT1A receptor. Conformational analysis combined with structure-affinity relationships (SAR) indicates that our arylpiperazines may bind at the 5-HT1A receptor in a nearly coplanar conformation. Observed interactions of the compounds in our 5-HT1A receptor model appeared to be in agreement with SAR data. The aromatic part of the arylpiperazine moiety has pi-pi interactions with the aromatic residues Trp161 and Phe362 in helices IV and VI, respectively. The positively charged protonated basic nitrogen forms a hydrogen bond with the negatively charged Asp116 in helix III. The ammonium-aspartate complex is surrounded by aromatic residues Trp358 and Phe361 in helix VI. A lipophilic pocket is formed by Phe362, Leu366 (both helix VI), and the methyl group of Thr200 (helix V). In agreement with the model, addition of a methyl substituent to the structure of the benzodioxine analogue 12 in this region, yielding 13, is favorable for 5-HT1A receptor affinity. Unfavorable positions for substitution with bulky groups, like the 3- and 4-positions in the benzofuran compound 14, are explained by steric hindrance with the backbone atoms of helix V. Thus, we were able to rationalize the 5-HT1A SAR of existing N1-phenylpiperazines, as well as a series of newly synthesized bicyclic heteroarylpiperazines, in terms of receptor-ligand interactions. Several of these N4-unsubstituted compounds had affinities in the low-nanomolar range.
为了探究对5-羟色胺1A受体(5-HT1A)具有高亲和力的结构要求,我们合成了一系列芳基取代的N1-苯基哌嗪,并评估了它们在大鼠额叶皮质匀浆中从其特异性结合位点置换[3H]-8-羟基二丙胺([3H]-8-OH-DPAT)的能力。我们发现2-甲氧基取代是有利的,而4-甲氧基取代对5-HT1A亲和力不利。除吡咯环外,在2,3-位稠合环的取代对所有研究的化合物都非常有利。在这类杂双环苯基哌嗪中,除氟取代外,所有其他取代都会使亲和力按邻位>对位>间位的顺序降低。邻位和对位亲和力的丧失可能是由于空间因素:取代基要么与受体产生空间位阻,要么阻止化合物采取与5-HT1A受体结合的合适构象。构象分析与构效关系(SAR)相结合表明,我们的芳基哌嗪可能以近乎共面的构象与5-HT1A受体结合。在我们的5-HT1A受体模型中观察到的化合物相互作用似乎与SAR数据一致。芳基哌嗪部分的芳香部分分别与螺旋IV和VI中的芳香族残基色氨酸161(Trp161)和苯丙氨酸362(Phe362)存在π-π相互作用。带正电荷的质子化碱性氮与螺旋III中带负电荷的天冬氨酸116(Asp116)形成氢键。铵-天冬氨酸复合物被螺旋VI中的芳香族残基色氨酸358(Trp358)和苯丙氨酸361(Phe361)包围。一个亲脂性口袋由苯丙氨酸362、亮氨酸366(均在螺旋VI中)和苏氨酸200(Thr200,螺旋V)的甲基形成。与该模型一致,在此区域向苯并二恶英类似物12的结构中添加一个甲基取代基,得到化合物13,有利于提高对5-HT1A受体的亲和力。对于用大体积基团取代的不利位置,如苯并呋喃化合物14中的3-位和4-位,可通过与螺旋V的主链原子产生空间位阻来解释。因此,我们能够根据受体-配体相互作用,对现有N1-苯基哌嗪以及一系列新合成的双环杂芳基哌嗪的5-HT1A构效关系作出合理说明。这些N4-未取代的化合物中有几种具有低纳摩尔范围内的亲和力。